| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/05/2001 | US20010007153 Solid chimeric organs, animal models having same, process for preparing same, non-tumorigenic immortalized human cell lines, susceptible cells and cytopathic mammalian viruses |
| 07/05/2001 | US20010007152 Obtained by immunizing transgenic mice which produce human leukocyte antigen (HLA) with tumor-associated antigens and recovering the nucleic acids encoding the T cell receptors from the cytotoxic T lymphocytes; diagnosis and therapy |
| 07/05/2001 | US20010006949 Methods and compositions for producing cells resistant to apoptosis |
| 07/05/2001 | US20010006947 Methods of administering adenoviral vectors |
| 07/05/2001 | US20010006813 Cultivation of eucaryotic cells |
| 07/05/2001 | US20010006810 Blood processing systems and methods using apparent hematocrit as a process of control parameter |
| 07/05/2001 | US20010006799 Histidine kinase polypeptides |
| 07/05/2001 | US20010006772 Method for conversion of blood type |
| 07/05/2001 | US20010006687 Honey-based composition for relief of occasional heartburn and digestive disorders |
| 07/05/2001 | US20010006682 Administering parenterally to the patient having suppressed immune system, an effective treatment amount of Product R, a peptide-nucleic acid preperation, alone or in combination with one or more immuno-modulators |
| 07/05/2001 | US20010006671 Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements |
| 07/05/2001 | US20010006642 Delivering antigens or biologically active polypeptides to a subject in need of same by administering to the subject a non-invasive or non-pathogenic bacterium which expresses the antigens or polypeptides |
| 07/05/2001 | US20010006634 Providing a bonding composition comprising isolated chondrocytes mixed with a biological gel, applying composition to a surface of first cartilage piece and contacting surface with second cartilage piece |
| 07/05/2001 | US20010006633 Adenovirus-chemotherapeutic combination for treating cancer |
| 07/05/2001 | US20010006630 Biological material such as cell, and purified extracellular matrix degrading enzyme externally adhered thereto; for treating mucopolysaccharidoses, cystic fibrosis, parkinson's disease, Gaucher's syndrome and osteogeneis imperfecta |
| 07/05/2001 | CA2395957A1 Process for ex vivo formation of mammalian bone and uses thereof |
| 07/05/2001 | CA2395950A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | CA2395382A1 Attenuated microorganisms for the treatment of infection |
| 07/05/2001 | CA2395328A1 Honey based food product for relief of stomach and intestine complaints and compressed product comprising said composition |
| 07/05/2001 | CA2394880A1 Activation and inhibition of the immune system |
| 07/05/2001 | CA2394295A1 Antibodies against plasma cells |
| 07/05/2001 | CA2394174A1 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/04/2001 | EP1113072A1 Tissue engineering using mandibular cells |
| 07/04/2001 | EP1112692A1 Drinks and foods capable of eliminating i helicobacter pylori /i |
| 07/04/2001 | EP1112371A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/04/2001 | EP1112368A1 Use of protein kinase kiaa0551 as pharmaceutical |
| 07/04/2001 | EP1112358A2 Dna sequence encoding oncofetal ferritin protein |
| 07/04/2001 | EP1112356A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancers |
| 07/04/2001 | EP1112090A2 Method of stimulating prosaposin receptor activity |
| 07/04/2001 | EP1112082A2 Stable liquid formulations of botulinum toxin |
| 07/04/2001 | EP1112078A2 New use |
| 07/04/2001 | EP0789586B1 Compounds for the prevention and treatment of helminth infections |
| 07/04/2001 | EP0621766B1 In vitro produced cornea equivalent model |
| 07/04/2001 | CN1302334A Retroviral delivery system |
| 07/04/2001 | CN1302330A Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 07/04/2001 | CN1302208A Smilagenin and anzurogenin-D for curing Alzheimer's disease |
| 07/04/2001 | CN1301563A Medicine for curing rheumatoid arthritis and preparing method |
| 07/04/2001 | CN1301561A Yang Strengthening impotence-eliminating decoction |
| 07/04/2001 | CN1301560A Method for preparing medicine for curing gastropathy |
| 07/04/2001 | CN1301555A Medicine for curing appendicitis and its preparing method |
| 07/04/2001 | CN1301554A Medicine for curing coronary heart disease |
| 07/04/2001 | CN1301552A Method for producing medicine for curing vertigo |
| 07/04/2001 | CN1301549A Method for producing chinese medicine for curing cardio-cerebrol vascular disease |
| 07/04/2001 | CN1301547A Analgesic plaster for osteoarthritis |
| 07/04/2001 | CN1301544A Medicinal composition for curing arthritis and osteoarthropathy and its preparing method |
| 07/04/2001 | CN1301543A Skin external use agent |
| 07/04/2001 | CN1301541A Health care product containing lactein and its preparing method |
| 07/04/2001 | CN1301540A Producing technology for three snake powder capsule |
| 07/04/2001 | CN1301539A Hemorrhoid medicine |
| 07/04/2001 | CN1301538A Melanin cell growth promotor for external use for skin and producing method thereof |
| 07/04/2001 | CN1068041C 花粉啤酒 Pollen beer |
| 07/04/2001 | CN1067911C Filter medium for leukocyte removal |
| 07/04/2001 | CN1067902C Decrustation ointment for burn and its preparing process |
| 07/04/2001 | CN1067900C Medicine bolus for hepatitis B and its preparing method |
| 07/04/2001 | CN1067899C Medicine for curing stone in urinary system |
| 07/04/2001 | CN1067898C Blood platelet regenerating pills and its preparation method |
| 07/04/2001 | CN1067885C Burn curing powder |
| 07/04/2001 | CN1067881C Hemostatic powder |
| 07/04/2001 | CN1067880C Pingyasan for hypertension |
| 07/04/2001 | CN1067878C Process for preparing anti-dote of soman intoxication |
| 07/04/2001 | CN1067877C Medicinal composition for curing scald |
| 07/03/2001 | US6256643 Systems and methods for storing, retrieving, and manipulating data in medical processing devices |
| 07/03/2001 | US6255457 Immunoglobulin for use as diagnositic tool and in preferential drug delivery |
| 07/03/2001 | US6255112 Co-culturing mesenchymal stem cells with hematopoietic stem cells to produce osteoclasts; the transduced cells express gene products that can be used to modulate bone resorption; therapy of osteoporosis |
| 07/03/2001 | US6255073 Cell segment from drosophila; for the treatment of cancer, tumors, viral or retroviral infection and autoimmune diseases |
| 07/03/2001 | US6254886 Multilayer tablet |
| 07/03/2001 | US6254870 Amino acid sequences |
| 07/03/2001 | US6254865 Method of treating huntington's disease using HNT neurons |
| 07/03/2001 | US6254862 Replication-competent adenovirus vectors |
| 07/03/2001 | CA2116348C Sirs vaccine and diagnosis method |
| 07/03/2001 | CA2078773C Gp75 as a tumor vaccine for melanoma |
| 06/28/2001 | WO2001046696A2 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | WO2001046455A2 Survivin promotion of angiogenesis |
| 06/28/2001 | WO2001046450A1 Replication incompetent herpes virus vectors |
| 06/28/2001 | WO2001046449A1 Replication incompetent herpes viruses for use in gene therapy |
| 06/28/2001 | WO2001046384A2 A method for isolating and purifying multipotential neural progenitor cells and multipotential neural progenitor cells |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001045835A1 Sensitive substance encapsulation |
| 06/28/2001 | WO2001045765A1 Tissue regenerative composition |
| 06/28/2001 | WO2001045751A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | WO2001045737A2 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth |
| 06/28/2001 | WO2001045736A1 Procedure to use staphylococcal bacteria |
| 06/28/2001 | WO2001045735A2 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 06/28/2001 | WO2001045722A1 Somnogenic activity of non-pathogenic lactic acid bacteria |
| 06/28/2001 | WO2001045721A1 Agent which is anti-adhesive in relation to the pathogenic flora of the skin |
| 06/28/2001 | WO2001045719A1 Virus-free plasma protein compositions treated with porous membrane and process for producing the same |
| 06/28/2001 | WO2001045718A1 A method of treating infectious diseases |
| 06/28/2001 | WO2001045669A1 Therapeutic use of particles displaying pathogen-specific binding moieties |
| 06/28/2001 | WO2001045510A1 Adeno-associated vectors for expression of factor viii by target cells |
| 06/28/2001 | WO2001021766A3 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 06/28/2001 | WO2000078927A3 Spheroid preparation |
| 06/28/2001 | WO2000078322A3 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 06/28/2001 | WO2000077186A3 Bacterial protection against stress |
| 06/28/2001 | WO2000076527A3 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
| 06/28/2001 | WO2000076450A3 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 06/28/2001 | WO2000075291A3 Cells with enforced expression of bcl-xl |
| 06/28/2001 | WO2000074693A3 Immunity generation |
| 06/28/2001 | WO2000073418A3 A method of using autologous fibroblasts to promote healing of wounds and fistulas |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |